Skip to main content

LadRx Corp

LADXDelisted
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000799698

LadRx Corp was delisted in 2025; its insiders filed their last Form 4 on Jan 29, 2024; no institution reported holding it in 13F filings for Q3 2025; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding LadRx Corp changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of LADX: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders32−1
Shares59.4K25.9K−33.5K (−56.4%)
Value$20.0K$2.00K−$18.0K (−90.0%)

New holders (0)

Institutions that held LadRx Corp at the end of Q2 2022 but not at the end of Q1 2022.

None.

Sold out (1)

Institutions that held LadRx Corp at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of LADX in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Beck Mack & Oliver LLC33,500$12.0K